Advanced in Pulmonary Fibrosis

Takefumi Saito

Naka, JP 
Advanced in Pulmonary Fibrosis
Naka, JP 
OverviewLocationsClinical Research

Overview

Takefumi Saito practices in Naka, Japan. Saito is rated as an Advanced expert by MediFind in the treatment of Pulmonary Fibrosis. Their top areas of expertise are Interstitial Lung Disease, Acute Interstitial Pneumonia, Idiopathic Pulmonary Fibrosis, and Pneumonia.

Their clinical research consists of co-authoring 77 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 7 articles and participated in 2 clinical trials in the study of Pulmonary Fibrosis.

Locations

Naka, 3191113, Japan
Other Locations
Japan
Tokai, Japan
Tokai, 3191113, Japan
Ibaraki, Japan
Naka, 3191113, Japan
Asahikawa, Japan
Kagoshima, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Japanese Idiopathic Interstitial Pneumonias Registry
Japanese Idiopathic Interstitial Pneumonias Registry
Enrollment Status: Active_not_recruiting
Publish Date: February 05, 2026
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Biological Activity, and PK of ND-L02-s0201 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Biological Activity, and PK of ND-L02-s0201 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Enrollment Status: Completed
Publish Date: December 11, 2023
Intervention Type: Drug, Other
Study Drug: ND-L02-s0201
Study Phase: Phase 2
View 1 Less Clinical Trial

81 Total Publications

Transcriptomic Profiling in Mycobacterium avium Complex Pulmonary Disease Identifies Clusters Linked to Disease Severity and Neutrophil Activation.
Transcriptomic Profiling in Mycobacterium avium Complex Pulmonary Disease Identifies Clusters Linked to Disease Severity and Neutrophil Activation.
Journal: American journal of respiratory and critical care medicine
Published: October 14, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Saito's expertise for a condition
ConditionClose
    View All 10 Advanced Conditions
    View All 29 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile